Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andy van Hateren

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Opinion in Immunology|July 15, 2021
The role of MHC I protein dynamics in tapasin and TAPBPR-assisted immunopeptidome editingAndy van Hateren, Tim Elliott
Biochemistry|February 23, 2018
Protein Plasticity and Peptide Editing in the MHC I Antigen Processing PathwayTim Elliott, Andy van Hateren
Current Opinion in Immunology|May 28, 2023
Visualising tapasin- and TAPBPR-assisted editing of major histocompatibility complex class-I immunopeptidomesAndy van Hateren, Tim Elliott
F1000Research|March 17, 2017
Recent advances in Major Histocompatibility Complex (MHC) class I antigen presentation: Plastic MHC molecules and TAPBPR-mediated quality controlAndy van Hateren, Alistair Bailey, Tim Elliott
Molecular Immunology|March 31, 2015
Plasticity of empty major histocompatibility complex class I molecules determines peptide-selector functionAndy van Hateren, Alistair Bailey, Jörn M Werner, et al.
Plos One|March 4, 2014
Two polymorphisms facilitate differences in plasticity between two chicken major histocompatibility complex class I proteinsAlistair Bailey, Andy van Hateren, Tim Elliott, et al.
The Journal of Biological Chemistry|October 13, 2017
Direct evidence for conformational dynamics in major histocompatibility complex class I moleculesAndy van Hateren, Malcolm Anderson, Alistair Bailey, et al.
The Journal of Biological Chemistry|October 1, 2013
A mechanistic basis for the co-evolution of chicken tapasin and major histocompatibility complex class I (MHC I) proteinsAndy van Hateren, Rachel Carter, Alistair Bailey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 20, 2015
Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope RecognitionSultan Abdul-Jawad, Beatrice Ondondo, Andy van Hateren, et al.
Immunotherapy Advances|September 30, 2022
De-risking clinical trial failure through mechanistic simulationLiam V Brown, Jonathan Wagg, Rachel Darley, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Opinion in Immunology|July 15, 2021
The role of MHC I protein dynamics in tapasin and TAPBPR-assisted immunopeptidome editingAndy van Hateren, Tim Elliott
Biochemistry|February 23, 2018
Protein Plasticity and Peptide Editing in the MHC I Antigen Processing PathwayTim Elliott, Andy van Hateren
Current Opinion in Immunology|May 28, 2023
Visualising tapasin- and TAPBPR-assisted editing of major histocompatibility complex class-I immunopeptidomesAndy van Hateren, Tim Elliott
F1000Research|March 17, 2017
Recent advances in Major Histocompatibility Complex (MHC) class I antigen presentation: Plastic MHC molecules and TAPBPR-mediated quality controlAndy van Hateren, Alistair Bailey, Tim Elliott
Molecular Immunology|March 31, 2015
Plasticity of empty major histocompatibility complex class I molecules determines peptide-selector functionAndy van Hateren, Alistair Bailey, Jörn M Werner, et al.
Plos One|March 4, 2014
Two polymorphisms facilitate differences in plasticity between two chicken major histocompatibility complex class I proteinsAlistair Bailey, Andy van Hateren, Tim Elliott, et al.
The Journal of Biological Chemistry|October 13, 2017
Direct evidence for conformational dynamics in major histocompatibility complex class I moleculesAndy van Hateren, Malcolm Anderson, Alistair Bailey, et al.
The Journal of Biological Chemistry|October 1, 2013
A mechanistic basis for the co-evolution of chicken tapasin and major histocompatibility complex class I (MHC I) proteinsAndy van Hateren, Rachel Carter, Alistair Bailey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 20, 2015
Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope RecognitionSultan Abdul-Jawad, Beatrice Ondondo, Andy van Hateren, et al.
Immunotherapy Advances|September 30, 2022
De-risking clinical trial failure through mechanistic simulationLiam V Brown, Jonathan Wagg, Rachel Darley, et al.
Pageof 2